Keller, Laura http://orcid.org/0000-0002-1786-9760
Pantel, Klaus http://orcid.org/0000-0001-5736-2772
Article History
Accepted: 9 July 2019
First Online: 27 August 2019
Competing interests
: K.P. has ongoing patent applications related to circulating tumour cells, and has received honoraria from Agena, Novartis, Roche and Sanofi and research funding from European Federation of Pharmaceutical Industries and Associations (EFPIA) partners (Angle, Menarini and Servier) of the CANCER-ID programme of the European Union–EFPIA Innovative Medicines Initiative. L.K. declares no competing interests.